CID 3359610

N-(1,3-thiazol-2-yl)-1,2,3,4-tetrahydro-9-acridinecarboxamide

Structural Information

Molecular Formula
C17H15N3OS
SMILES
C1CCC2=NC3=CC=CC=C3C(=C2C1)C(=O)NC4=NC=CS4
InChI
InChI=1S/C17H15N3OS/c21-16(20-17-18-9-10-22-17)15-11-5-1-3-7-13(11)19-14-8-4-2-6-12(14)15/h1,3,5,7,9-10H,2,4,6,8H2,(H,18,20,21)
InChIKey
LGPIFVVGQHRDOK-UHFFFAOYSA-N
Compound name
N-(1,3-thiazol-2-yl)-1,2,3,4-tetrahydroacridine-9-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

309.0936 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 310.10088 166.9
[M+Na]+ 332.08282 181.1
[M+NH4]+ 327.12742 176.5
[M+K]+ 348.05676 172.6
[M-H]- 308.08632 172.1
[M+Na-2H]- 330.06827 174.9
[M]+ 309.09305 170.9
[M]- 309.09415 170.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.